Inventor · disambiguated record
Nigel Ramsden
Also filed as: RAMSDEN NIGEL · RAMSDEN NIGEL GRAHAME
16 granted patents·27 pending applications·62 citations·filing 1999–2023
90Inventor score
Files withCELLZOME LTD5CENTESSA PHARMACEUTICALS UK LTD5HARRISON RICHARD JOHN4RAMSDEN NIGEL4Z FACTOR LTD4
Top patents by PatentIndex Score
43 records- 0190US11312689B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyZ FACTOR LTD·Filed 2021·Granted Apr 26, 2022·4 cites·8 claims
- 0278US9296725B2Heterocyclyl pyrimidine analogues as TYK2 inhibitorsCELLZOME LTD·Filed 2013·Granted Mar 29, 2016·6 cites·16 claims
- 0375US8883820B2Triazole derivatives as kinase inhibitorsWILSON FRANCIS·Filed 2007·Granted Nov 11, 2014·5 cites·27 claims
- 0474US8785457B2Pyrimidine derivatives as mTOR inhibitorsLYNCH ROSEMARY·Filed 2010·Granted Jul 22, 2014·4 cites·8 claims
- 0570US7091237B2Furan and thiophene derivatives that activate human peroxisome proliferator activated receptorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 15, 2006·5 cites·22 claims
- 0669US12221422B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Feb 11, 2025·0 cites·10 claims
- 0768US8865699B2Amino triazoles as PI3K inhibitorsRAMSDEN NIGEL·Filed 2008·Granted Oct 21, 2014·2 cites·28 claims
- 0868US6867192B1Compounds useful in the treatment of inflammatory diseasesFiled 1999·Granted Mar 15, 2005·34 cites·20 claims
- 0964US12291507B2Compounds and their use for the treatment of ALPHA1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted May 6, 2025·0 cites·20 claims
- 1064US12286402B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Apr 29, 2025·0 cites·19 claims
- 1162US2024197707A1Compositions and their Use for the Treatment of A1-Antitrypsin DeficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2023·Application pending·0 cites
- 1260US12365672B2Compounds and their use for the treatment of alpha1-antitrypsin deficiencyCENTESSA PHARMACEUTICALS UK LTD·Filed 2022·Granted Jul 22, 2025·0 cites·13 claims
- 1359US8153389B2Methods for the identification of PI3K interacting molecules and for the purification of PI3KBERGAMINI MOORE GIOVANNA·Filed 2007·Granted Apr 10, 2012·1 cites·21 claims
- 1458US9242987B2Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitorsRAMSDEN NIGEL·Filed 2010·Granted Jan 26, 2016·1 cites·19 claims
- 1557US2024327357A14-((6-oxopyrimidin-1(6h)-yl)methyl)benzoic acid as an inducer of z a1at secretion for treating aatdZ FACTOR LTD·Filed 2022·Application pending·0 cites
- 1653US2023089087A1Compounds and their use for the treatment of alpha1-antitrypsin deficiencyZ FACTOR LTD·Filed 2022·Application pending·0 cites
- 1751US2023102488A1Compounds and their use for the treatment of alpha1-antitrypsin deficiencyZ FACTOR LTD·Filed 2022·Application pending·0 cites
- 1848US2011028405A1Sulfamides as zap-70 inhibitorsHARRISON RICHARD JOHN·Filed 2008·Application pending·0 cites
- 1948US2011098288A1Sulfonamides as zap-70 inhibitorsMAJOR JEREMY·Filed 2009·Application pending·0 cites
- 2047US2014296234A1Pyrimidine derivatives as mtor inhibitorsCELLZOME LTD·Filed 2014·Application pending·0 cites
- 2144US2012178180A1Methods for the identification of zap-70 interacting molecules and for the purification of zap-70KRUSE ULRICH·Filed 2007·Application pending·0 cites
- 2243US2004039020A1Novel pharmaceutical formulation suitable for nebulisationFiled 2001·Application pending·0 cites
- 2342US2013210664A1Methods for the Identification of Methyltransferase Interacting Molecules and for the Purification of Methyltransferase ProteinsHARRISON JOHN·Filed 2011·Application pending·0 cites
- 2441US8367830B2Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteinsCELLZOME AG·Filed 2010·Granted Feb 5, 2013·0 cites·14 claims
- 2540US9655897B2Heterocyclyl pyrimidine analogues as TYK2 inhibitorsCELLZOME LTD·Filed 2016·Granted May 23, 2017·0 cites·14 claims
- 2639US9040545B2Heterocyclyl pyrazolopyrimidine analogues as selective JAK inhibitorsBELL KATHRYN·Filed 2011·Granted May 26, 2015·0 cites·5 claims
- 2738US2014323504A1Pyrazolo[4,3-c]Pyridine Derivatives As Kinase InhibitorsCELLZOME LTD·Filed 2012·Application pending·0 cites
- 2838US2015005281A1Pyrimidine-2,4-diamine derivatives as kinase inhibitorsCELLZOME LTD·Filed 2012·Application pending·0 cites
- 2938US2004147557A1Aryl piperidine derivatives as inducers of ldl-receptor expressionFiled 2001·Application pending·0 cites
- 3038US2004072865A1Aryl piperidine derivatives as inducers of ldl-receptor expressionFiled 2001·Application pending·0 cites
- 3138US2004077654A1Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expressionFiled 2001·Application pending·0 cites
- 3237US2014179664A1Heterocyclyl Pyrimidine Analogues As JAK InhibitorsFREEMAN JAY·Filed 2012·Application pending·0 cites
- 3336US2013131043A1Pyrazole compounds as jak inhibitorsHARRISON RICHARD JOHN·Filed 2011·Application pending·0 cites
- 3436US2004037784A1Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonistFiled 2001·Application pending·0 cites
- 3536US2004034058A1Novel pharmaceutical formulation suitable for nebulisationFiled 2001·Application pending·0 cites
- 3636US2004034062A1Novel aqueous anti-inflammatory pharmaceutical formulationFiled 2001·Application pending·0 cites
- 3735US2004039021A1Pharmaceutical anti-inflammatory aerosol formulationFiled 2001·Application pending·0 cites
- 3835US2004044035A1Novel aqueous anti-inflammatory pharmaceutical formulationFiled 2001·Application pending·0 cites
- 3934US2012172385A1Ortho substituted pyrimidine compounds as jak inhibitorsHARRISON RICHARD JOHN·Filed 2010·Application pending·0 cites
- 4033US2012040955A1Fluoro substituted pyrimidine compounds as jak3 inhibitorsHARRISON RICHARD JOHN·Filed 2010·Application pending·0 cites
- 4132US2013143915A1Triazolopyridines as tyk2 inhibitorsELLARD KATIE·Filed 2011·Application pending·0 cites
- 4231US2012270237A9Methods for the identification of kinase interacting molecules and for the purification of kinase proteinsRAMSDEN NIGEL·Filed 2010·Application pending·0 cites
- 4329US2012142667A1Pyrimidine derivatives as zap-70 inhibitorsRAMSDEN NIGEL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nigel Ramsden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →